&nbsp;

Asset 4.png

Sep 2019

Document

Asset 5.png

Sep 2019

Document

Asset 7.png

Sep 2019

Regimen

ALEM

Cancer Type:

Hematologic,

Lymphoma - T-cell,

Rare Diseases

Intent: Palliative

Drugs Used:

alemtuzumab (Compassionate)

Quick Link(s):

Regimen Monograph

Sep 2019

Document

uiTabsThumbTab.png

Sep 2019

Document

uiTabsThumbTab-2.png

Oct 2019

Regimen

ATEZ(MNT)

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

atezolizumab,

atezolizumab (subcut)

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

ATEZBEVA(MNT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

atezolizumab (Unfunded),

bevacizumab (Unfunded)

Quick Link(s):

Regimen Monograph

May 2025

Regimen

AC-PACL(W)+PERT+TRAS

Cancer Type:

Breast

Intent: Curative, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

DOXOrubicin,

cyclophosphamide,

PACLitaxel,

PERTuzumab (Unfunded),

trastuzumab

Quick Link(s):

Regimen Monograph

Sep 2022

Regimen

AC-PACL(DD)+PERT+TRAS

Cancer Type:

Breast

Intent: Curative, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

DOXOrubicin,

cyclophosphamide,

PACLitaxel,

PERTuzumab (Unfunded),

trastuzumab